View in EDS HTML Full Text PDF Full Text

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial.

Saved in:
Bibliographic Details
Title: Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial.
Authors: Alsaleh, K.1 (AUTHOR) khalid_alsaleh@hotmail.com, Al Zahwahry, H.2 (AUTHOR), Bounedjar, A.3 (AUTHOR), Oukkal, M.4 (AUTHOR), Saadeddine, A.5 (AUTHOR), Mahfouf, H.6 (AUTHOR), Bouzid, K.7 (AUTHOR), Bensalem, A.8 (AUTHOR), Filali, T.9 (AUTHOR), Abdel-Razeq, H.10 (AUTHOR), Larbaoui, B.11 (AUTHOR), Kandil, A.12 (AUTHOR), Abulkhair, O.13 (AUTHOR), Al Foheidi, M.14 (AUTHOR), Ghosn, M.15 (AUTHOR), Rasool, H.16 (AUTHOR), Boussen, H.17 (AUTHOR), Mezlini, A.18 (AUTHOR), Haddaoui, A.18 (AUTHOR), Ayari, J.19 (AUTHOR)
Source: Journal of Cancer Research & Clinical Oncology. Aug2023, Vol. 149 Issue 9, p6171-6179. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01715216
DOI:10.1007/s00432-023-04588-3